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Internal hemorrhoids are one of the most commonly diag-
nosed benign anorectal disorders worldwide. They are treated, 
in part, using suppositories or ointment application in con-
junction with preventing straining while defecating. However, 
additional intervention is required when symptoms become 
aggravated. In Japan, conventional hemorrhoidectomy has 
been widely applied for correcting prolapsed internal hemor-
rhoids. Unfortunately, it is accompanied by postoperative pain 
and hospitalization, requiring absence from the work place for 
2–3 weeks. Recently, several alternative treatment options have 
become available for patients who do not respond to conser-
vative medical management. Rubber band ligation and sclero-
therapy have been shown to be simple and safe treatments for 
hemorrhoids. The most common sclerosing agent, 5% phenol 
almond oil, has been considered ineffective, so an aluminum 
potassium sulfate and tannic acid (ALTA) combination has 
been developed in Japan by adjusting certain constituents of 
the Xiaozhiling, a sclerosing agent developed by Shi in the 
1970s.1,2 This agent induces an inflammatory reaction resulting 
in fibrosis, which increases support to tissues while preventing 
recurrence of prolapse and hemorrhage.3 An early clinical 
study conducted in Japan indicated that the rate of resolution 
for prolapsing hemorrhoids after an ALTA injection exceeded 
90%, similar to the prognosis after surgery.4 Follow-up studies 
showed shorter durations of procedure time and hospital stay, 
a lower frequency of postoperative pain, and a higher rate of 
prolapse disappearance with ALTA therapy than with ligation, 
excision, or other procedures.2,5,6 The cumulative success rate 
of ALTA sclerotherapy in a 5-year follow-up study was also 
satisfactory (78.2%–89.3%).
In this issue of Clinical Endoscopy, Tomiki et al. reported 
that endoscopic ALTA sclerotherapy was equivalent to stan-
dard ALTA therapy in terms of efficacy, adverse events, and 
recurrence of hemorrhoids.7 In this retrospective study, they 
compared two groups with regard to therapeutic effects, pa-
tient satisfaction, adverse events such as fever and anal pain, 
and the recurrence rate during a 1-year follow-up period. One 
month after the procedures, 97.0% of patients in the standard 
ALTA group experienced therapeutic effects ranging from 
improvement to cure, and 95.8% of patients in the endoscopic 
ALTA group experienced therapeutic effects. The patients 
reported good satisfaction (very satisfied or satisfied) at all 
the same time-points in the standard (93.9%) and endoscopic 
(95.8%) ALTA groups. Hemorrhoids recurred in two patients 
(6.3%) from the standard ALTA group and in four (8.3%) 
from the endoscopic ALTA group. Adverse events occurred 
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in four patients (12.1%) in the standard ALTA group and 
in six (12.5%) in the endoscopic ALTA group. Among these 
measures, there were no statistically significant differences be-
tween the two groups. The injection dose was 21.9±7.2 mL in 
the standard ALTA group and 17.8±3.4 mL in the endoscopic 
ALTA group, which was significantly different (p<0.01). 
In the present study, the authors performed a careful, thor-
ough standard vs. endoscopic procedure using a lower ALTA 
dose as a precaution, yet the therapeutic effect was overall sat-
isfactory. It is expected that the ALTA dose can be increased 
in future while monitoring patients for adverse events. Endo-
scopic ALTA may be less embarrassing, especially for women, 
when comparing the left lateral decubitus position with Sim’s 
position. Using a flexible endoscope is also beneficial when 
performing a standardized 4-step injection procedure because 
the visual field is clearly displayed as a high definition image 
and a precise injection can be accomplished by fine position-
ing of the scope. Along with further development of endo-
scopic ALTA, additional research including a multi-center, 
prospective randomized study with a large number of cases 
must be conducted. Currently, it is reasonable to conclude that 
endoscopic ALTA is a less invasive and comparably efficacious 
therapeutic strategy for hemorrhoids, which should make a 
large market diffusion for this option.
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